Top Tweets for #ScienceFirstForPatients
Tadaaki Taniguchi, Chief Medical Officer, shares his insights with @PharmaVoice on how to help teams adopt agile ways of working and thrive outside their comfort zones to meet the urgent needs of patients. #Changingtomorrow #ScienceFirstForPatients

With growing recognition that partnerships are vital to accelerate our innovation, SVP, Primary Focus Lead Immuno-oncology, Peter Sandor shared his thoughts with @_CellandGene on how to advance a new era of cancer cell therapies. #ScienceFirstForPatients

As the pharma industry rethinks clinical trial approaches, Marie Rosenfeld, SVP, Head of Clinical Science shares her thoughts with @ClinicalLeader1 about what Astellas has learned so far: https://t.co/STgggSYVEU.
#ChangingTomorrow #ScienceFirstForPatients

A shared culture of quality is a critical enabler of accelerating innovation. Our Head of Quality Assurance, David Fryrear, shares his thoughts with
@PharmExec.
#ChangingTomorrow #ScienceFirstForPatients

What does it take to deliver next generation #cancer therapies and build a leadership position from the ground up?
Join us and @endpts as we discuss all things strategy, innovation, culture and partnerships. #ScienceFirstForPatients

SVP, Primary Focus Lead Immuno-oncology, Peter Sandor speaks to @fwpharma, exploring how partnerships with a shared commitment to creating the right environment for innovation to flourish are some of the most powerful. Learn more https://t.co/fey7gW247L #ScienceFirstForPatients

How can pharma evolve its approach to decentralized #clinicaltrials to give patients more choices? Our Head of Clinical Sciences Marie Rosenfeld shares her views with @medcitynews https://t.co/SVGtT0OhlJ. #ScienceFirstForPatients

We’re working with the cancer community to find and accelerate the cures of tomorrow. Our Primary Focus Lead Immuno-oncology, Peter Sandor, shares how collaboration and new ways of working are driving progress for patients. #ChangingTomorrow #ScienceFirstForPatients

Regulatory reform is ongoing globally and we have a unique opportunity to assess how we can deliver even greater value for patients. Our Head of Regulatory Affairs Stef Schutte shares his thoughts with @PharmExec. #ChangingTomorrow #ScienceFirstForPatients

Our Chief Medical Officer Bernie Zeiher shares his five key lessons for innovating at the frontiers of science.
Read the article in @statnews to learn more.
#ChangingTomorrow
#ScienceFirstForPatients
We are dedicating our collective strengths to find new ways to treat more cancers in more patients. Hear how we are transforming R&D in #immuno-oncology to redefine expectations of #cancer care and read on to learn more. #ChangingTomorrow #ScienceFirstForPatients
Are we doing all we can to unlock the full potential of #RealWorldEvidence for patients? Our Medical Affairs leaders Charlotte Kremer and Judith Nelissen share their thoughts with @INVIVOnow. #ScienceFirstForPatients
Weatherwax Biotechnologies and Vcreate win our two Astellas Future Innovator Prizes, granting a year’s access to @MBiolabs incubator and our R&D mentors! We are proud to support these #entrepreneurs to advance their #innovations. #ScienceFirstForPatients
Instilling a culture of quality is key to realize the full potential of tomorrow’s innovation. Our Head of Quality Assurance David Fryrear shares his thoughts with @ThePharmaLetter. #ScienceFirstForPatients
Thymmune Therapeutics and M13 Therapeutics win our two Astellas Future Innovator Prizes, granting a year’s access to @LabCentral incubator and our R&D mentors! We are proud to support these #entrepreneurs to advance their #innovations. #ScienceFirstForPatients
SVP Joe Fleishaker shares how Astellas’ expert Clinical Pharmacology and Exploratory Development team helps to maximize the value of our therapies for patients. Read on to learn more. #ClinicalPharmacology #ScienceFirstForPatients #2021ACCP
“Quality and excellence are the foundation of our work in healthcare.” CMO Bernie Zeiher shares insights with @PharmExec on the importance of embracing a ‘quality by design’ mindset to meet the needs of patients. #ChangingTomorrow #ScienceFirstForPatients
Chief Medical Officer Bernie Zeiher shares his thoughts on the key lessons the pandemic taught biopharma and what they may hold for the future. #ChangingTomorrow #ScienceFirstForPatients
Chief Business Officer Percival Barretto-Ko talks with @LEADERSMag about his new role driving innovation at Astellas, our inclusive culture and how we are focused on #ScienceFirstforPatients to create new medical solutions that bring value to patients with high unmet needs.
“There’s nothing stopping us moving with the same sense of urgency and patient-partnership in the post COVID-19 world,” shared Bernie Zeiher, our CMO, with @INVIVOnow. #ScienceFirstForPatients
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.2M followers

Barack Obama 
@barackobama
119.3M followers

Donald J. Trump 
@realdonaldtrump
111.6M followers

Cristiano Ronaldo 
@cristiano
109.3M followers

Narendra Modi 
@narendramodi
106.9M followers

Rihanna 
@rihanna
97.4M followers

NASA 
@nasa
92.1M followers

Justin Bieber 
@justinbieber
90.6M followers

KATY PERRY 
@katyperry
87M followers

Taylor Swift 
@taylorswift13
80.8M followers

Lady Gaga 
@ladygaga
72.4M followers

Kim Kardashian 
@kimkardashian
69.5M followers

Virat Kohli 
@imvkohli
68.9M followers

YouTube 
@youtube
68.6M followers

Bill Gates 
@billgates
63.5M followers

The Ellen Show
@theellenshow
62.5M followers

CNN 
@cnn
61.9M followers

Neymar Jr 
@neymarjr
61.5M followers

X 
@x
60.9M followers

Selena Gomez 
@selenagomez
60.1M followers
